LYMPHOMA, MANTLE-CELL
Clinical trials for LYMPHOMA, MANTLE-CELL explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA, MANTLE-CELL trials appear
Sign up with your email to follow new studies for LYMPHOMA, MANTLE-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill shows promise for hard-to-treat blood cancers in chinese patients
Disease control CompletedThis study tested an oral drug called LOXO-305 in 87 Chinese adults with chronic lymphocytic leukemia, small lymphocytic lymphoma, or non-Hodgkin lymphoma whose cancer had returned or not responded to prior treatments. The main goal was to see how many patients had their tumors s…
Matched conditions: LYMPHOMA, MANTLE-CELL
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 26, 2026 11:58 UTC
-
New combo therapy offers hope for Tough-to-Treat lymphoma
Disease control CompletedThis study tested a combination of ibrutinib and rituximab against other standard treatments for people with mantle cell lymphoma that had come back or stopped responding. The main goal was to monitor side effects and provide continued access to treatment for those who were benef…
Matched conditions: LYMPHOMA, MANTLE-CELL
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 26, 2026 11:57 UTC
-
New combo therapy shows promise for elderly lymphoma patients
Disease control CompletedThis study tested whether adding the drug venetoclax to standard chemotherapy (R-BAC) helps older patients with high-risk mantle cell lymphoma live longer without their cancer getting worse. The trial involved 141 patients aged 65 and older (or younger if unable to have a transpl…
Matched conditions: LYMPHOMA, MANTLE-CELL
Phase: PHASE2 • Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Disease control
Last updated May 15, 2026 11:54 UTC